Omeros Corporation Banner Image

Omeros Corporation

  • Ticker OMER
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Omeros Corporation Logo Image
  • 51-200 Employees
  • Based in Seattle, Washington
Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. It markets Omidria for use during cataract surgery or intraocular lens, or replacement surgery.
Omeros Corporation

Most Recent Annual Report

Omeros Corporation
MOST RECENT 2021 Annual Report and Form 10K

Omeros Corporation does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports